Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00164372 · ClinicalTrials.gov registry record · Phase 2
Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,400
- Enrollment target
NCT00164372: Completed Phase 2 study, sponsored by Centers for Disease Control and Prevention.
NCT00164372 is a Phase 2 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,400 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (953% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00164372, a Phase 2 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,400 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether a six-session behavioral intervention for HIV and HCV seronegative injection drug users is effective in reducing sexual and injection risk behaviors that could lead to primary HIV and HCV infection.
Interventions
- BEHAVIORAL Peer Education Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2002-05 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
What the finished NCT00164372 record still lists
NCT00164372 is an interventional study that assigns participants to a tested intervention. Its 1,400 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (953% higher).
The record links to 0 conditions, and to 1 intervention - of which Peer Education Intervention is the first listed.
NCT00164372 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00164372 about?
NCT00164372 is a clinical study titled "Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users". The purpose of this study is to test whether a six-session behavioral intervention for HIV and HCV seronegative injection drug users is effective in reducing sexual and injection risk behaviors that could lead to primary HIV and HCV infection.
What is the current status of trial NCT00164372?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,400 participants. The study started on 2002-05. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00164372?
The interventions under investigation include: Peer Education Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00164372?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00164372's enrollment target sits among peer trials
1,400 12th of 2000 higher than 1,988 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
- NCT03145077 · 1,400 participants · NA
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
- NCT04250857 · 1,400 participants
HeartStart FRx Defibrillator Event Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia